Observational study in European stroke journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
39 authors.
Ines PiotDepartment of Neurology and Stroke Center, University Hospital Basel, Basel, Switzerland.ORCID 0000-0001-8502-7453
Lukas S EnzDepartment of Neurology and Stroke Center, University Hospital Basel, Basel, Switzerland.ORCID 0000-0002-6588-2142
Valerian L AltersbergerDepartment of Neurology and Stroke Center, University Hospital Basel, Basel, Switzerland.ORCID 0000-0002-0610-9328
Simon TrüsselDepartment of Neurology and Stroke Center, University Hospital Basel, Basel, Switzerland.ORCID 0009-0004-2537-855X
Gian Marco De MarchisDepartment of Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland.ORCID 0000-0002-0342-9780
Tolga DittrichDepartment of Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland.ORCID 0000-0002-9987-3631
Mirjam R HeldnerDepartment of Neurology and University Institute of Diagnostic and Interventional Neuroradiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.ORCID 0000-0002-3594-2159
Julian F HotzDepartment of Neurology and University Institute of Diagnostic and Interventional Neuroradiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.ORCID 0000-0003-0270-790X
Greta SoekelandDepartment of Neurology and University Institute of Diagnostic and Interventional Neuroradiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.ORCID 0000-0002-3990-8492
Tomas DobrockyDepartment of Neurology and University Institute of Diagnostic and Interventional Neuroradiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.ORCID 0000-0002-6167-3343
Alessandro PezziniDepartment of Medicine and Surgery, University of Parma, Parma, Italy.ORCID 0000-0001-8629-3315
Patrik MichelStroke Center, Service of Neurology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.ORCID 0000-0003-4954-7579
Davide StramboStroke Center, Service of Neurology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.ORCID 0000-0003-4429-2714
Alexander SalernoStroke Center, Service of Neurology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.ORCID 0000-0001-8494-5527
Susanne WegenerDepartment of Neurology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.ORCID 0000-0003-4369-7023
Corinne InauenDepartment of Neurology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.ORCID 0000-0002-7786-2720
Philipp BaumgartnerDepartment of Neurology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.ORCID 0000-0003-1525-2019
Sami CurtzeDepartment of Neurology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.ORCID 0000-0003-1545-8500
Nicolas Martinez-MajanderDepartment of Neurology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.ORCID 0000-0001-8489-7051
Paul J NederkoornDepartment of Neurology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0001-7386-4545
Jonathan M CoutinhoDepartment of Neurology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0002-8284-982X
Christian H NolteDepartment of Neurology with Experimental Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID 0000-0001-5577-1775
Christoph RieglerDepartment of Neurology with Experimental Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID 0000-0002-2478-3500
Visnja PadjenNeurology Clinic, University Clinical Centre of Serbia, and Faculty of Medicine, University of Belgrade, Belgrade, Serbia.ORCID 0000-0002-6126-8305
Ronen R LekerDepartment of Neurology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.ORCID 0000-0003-4794-0334
Hamza JubranDepartment of Neurology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.ORCID 0009-0009-8228-1347
Malin WoockDepartment of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden.ORCID 0000-0002-9291-3151
Katarina JoodDepartment of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden.ORCID 0000-0001-8746-1771
Alexandros RentzosDepartment of Radiology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.ORCID 0000-0001-6610-7802
Carlo W CeredaStroke Center, Department of Neurology, Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale (EOC), Lugano, Switzerland.ORCID 0000-0002-6479-1476
Marco VabanesiStroke Center, Department of Neurology, Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale (EOC), Lugano, Switzerland.
Andrea ZiniDepartment of Neurology and Stroke Center, IRCCS Istituto delle Scienze Neurologiche di Bologna, Maggiore Hospital, Bologna, Italy.ORCID 0000-0003-1486-4507
Matteo PaolucciDepartment of Neurology and Stroke Center, IRCCS Istituto delle Scienze Neurologiche di Bologna, Maggiore Hospital, Bologna, Italy.ORCID 0000-0002-5347-378X
João Pedro MartoDepartment of Neurology, Hospital de Egas Moniz, ULS Lisboa Ocidental, Lisbon, Portugal.ORCID 0000-0003-2277-5950
Alexandra MartinsDepartment of Neurology, Hospital de Egas Moniz, ULS Lisboa Ocidental, Lisbon, Portugal.ORCID 0009-0001-9311-3121
Jeremy MoladDepartment of Stroke & Neurology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.ORCID 0000-0001-6868-4849
Stefan T EngelterDepartment of Neurology and Stroke Center, University Hospital Basel, Basel, Switzerland.ORCID 0000-0003-3855-6234
Henrik GensickeDepartment of Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland.ORCID 0000-0002-0949-2422
For The EndoVAscular Treatment And Thrombolysis For Ischemic Stroke Patients Eva-Trisp Collaborators
Funding
Goldschmidt-Jacobson Foundation
6 · The paper itself
Abstract
introductionAcute EVT may be withheld from stroke patients with prestroke dependency on the help of others in daily activities because of insufficient randomised evidence. Using data from a large registry, we aimed to improve evidence for EVT decision-making in these patients. PATIENTS AND
methodsMulticentre international observational study from the EndoVascular Therapy and ThRombolysis in Ischemic Stroke Patients (EVA-TRISP) collaboration comparing prestroke-dependent (prestroke mRS 3-4) with prestroke-independent patients (prestroke mRS 0-2). We used multivariate logistic regression analysis and report odds ratios (ORs) and 95% CIs. Outcomes were poor functional outcome in survivors (defined relative to the prestroke mRS), 3 month mortality, sICH occurrence and unsuccessful recanalisation.
resultsOf 13,525 eligible patients, 1436 (10.6%) were prestroke-dependent. These patients were older (median 84 vs 73 years), more often women (61.0% vs 46.7%) and had higher NIHSS score (median 16 vs 14 points). While the odds of death (ORadjusted 2.33 [95% CI, 2.04-2.66]; 48.6% vs 19.6%) and unsuccessful recanalisation (ORadjusted 1.16 [95% CI, 1.02-1.33]; 31.0% vs 26.6%) were higher in prestroke-dependent patients, there was no evidence of increased odds of poor functional outcome in survivors (ORadjusted 0.68 [95% CI, 0.57-0.81]; 42.8% vs 40.0%) and sICH (ORadjusted 0.72 [95% CI, 0.53-0.98]; 3.8% vs 4.6%). DISCUSSION AND
conclusionsDespite higher mortality and recanalisation failure, prestroke-dependent patients did not have worse functional outcomes among survivors or higher sICH risk. This suggests that EVT should not be withheld solely on the basis of prestroke dependency.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Endovascular therapy in acute ischaemic stroke patients with prestroke dependency-an EVA-TRISP cohort study. · full record | Socratic